Neovasc Reducer Featured in Three Peer Reviewed Publications Supporting Reducer Therapy
Vancouver, Bristish Columbia and Minneapolis, Minnesota–(Newsfile Corp. – January 19, 2021) – Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) (“Neovasc” or the “Company”) announced today that the Neovasc Reducer™ (“Reducer”) was prominently featured in three peer more...
Inotiv Broadens Pathology Service Offerings
WEST LAFAYETTE, Ind., Jan. 19, 2021 (GLOBE NEWSWIRE) — Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”) , doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, more...
Youngevity International, Inc. Announces Declaration of Monthly Dividend for 1st Quarter 2021 for Series “D” Cumulative Redeemable Perpetual Preferred Stock
Youngevity International, Inc. Announces Declaration of Monthly Dividend for 1st Quarter 2021 for Series “D” Cumulative Redeemable Perpetual Preferred Stock PR Newswire SAN DIEGO , Jan. 19, 2021 /PRNewswire/ — Youngevity International, Inc. (OTCM : more...
Avinger Expands Intellectual Property Portfolio
19 New U.S. and International Patents Issued and Allowed in 2020 REDWOOD CITY, CA / ACCESSWIRE / January 19, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular more...
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Cardiac Surgery Enhanced Recovery Regimen
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Cardiac Surgery Enhanced Recovery Regimen PR Newswire REDWOOD CITY, Calif. , Jan. 19, 2021 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on more...
WeedMD Announces the Development of New Cannabis 2.0 Products Featuring Hash, Live Resin and Rosin Extracts for Adult-Use Lineup
Expanded product portfolio using indoor and outdoor-grown, terpene-rich biomass to debut in Q2 2021 TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) — WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company more...
America’s #1 Dad Todd Chrisley Partners with Beckett’s Non-Alcoholic Spirits to Celebrate Safe Spirited Partying
THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES OR TO U.S. PERSONS. LOS ANGELES, Jan. 19, 2021 (GLOBE NEWSWIRE) — Beckett’s Tonics California, a subsidiary of The Tinley Beverage Company Inc. (OTC:TNYBF, more...
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2020 Revenues and Provides 2021 Strategic Outlook
Achieved Fourth Quarter 2020 Preliminary Unaudited Total Revenues of $13.9 Million, the Highest Revenue Quarter for the Company Since Inception Full Year 2020 Preliminary Unaudited Total Revenues of $42.2 Million, a 44% Increase Over Full more...
Galmed Hosting KOL Symposium and Pipeline Update
Galmed Hosting KOL Symposium and Pipeline Update Aramchol Phase 3 Trial for Non-Alcoholic Steatohepatitis and Liver Fibrosis Amilo-5MER for Chronic Inflammatory Disorders Symposium Being Held January 26th at 11am Eastern Time PR Newswire TEL AVIV, more...
Advaxis Announces Receipt of Funding Milestone Payment Under ADXS-HER2 Licensing Agreement with OS Therapies
Non-dilutive capital strengthens balance sheet to further advance ADXS-HOT neoantigen program PRINCETON, N.J., Jan. 19, 2021 (GLOBE NEWSWIRE) — Advaxis, Inc. (NASDAQ: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy more...